Superior photo-induced antibacterial/antibiofilm activities of ZnPcs/TiO2 and computational simulation studies.

Bacteria can form biofilms on any surface, which causes biofilm-associated infections and bacterial resistance to antibiotics. Thus, it is important to design new-generation non-chemotherapeutic nanoagents for effective antibacterial and antibiofilm strategies. Herein, the effects of the anchoring groups, which are imidazole and carboxylic acid, of zinc phthalocyanines (ZnPcs) sensitized TiO2 on Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were investigated under light-emitting diode (LED) irradiation. The photocatalytic antibacterial activities of ZnPc-1/TiO2 and ZnPc-2/TiO2 on the bacterial strains were examined by monitoring the optical density value at 600 nm (OD600 nm). Glutathione (GSH) oxidation assay was used to measure the reactive oxygen species (ROS) generation activity of the compounds. Bacterial damages were imaged by scanning electron microscopy (SEM). According to our photocatalytic antibacterial mechanism, photogenerated electrons are transferred from Pcs to TiO2 and then react with O2, thus creating ROS, which causes damage to bacterial membrane, protein and biofilm destruction as well. Further, computational simulation analysis was used to show the interaction patterns of ZnPc-1 and ZnPc-2 with penicillin binding protein 2a (PBP2a) of S. aureus and FimH lectin protein (PDB:4XO8) of E. coli to elucidate the dark molecular antibacterial mechanism of the compounds. The obtained results from computational studies showed that ZnPc-2 binds firmly through bonds with the 1MWT protein from S. aureus. On the other hand, ZnPc-1 binds firmly through bonds with the 4XO8 protein from E. coli. From combining experimental and computational results, we can conclude that this strategy can be applied to different types of bacterial infections.

Imidazole substituted Zinc(II) phthalocyanines for co-catalyst-free photoelectrochemical and photocatalytic hydrogen evolution: influence of the anchoring group.

Novel zinc phthalocyanine derivatives, ZnPc-1 and ZnPc-2, consisting of one and four imidazole units, respectively, have been synthesized and utilized as panchromatic photosensitizers for photocatalytic and photoelectrochemical H2 evolution. The effect of the imidazole-anchoring group on the photocatalytic H2 production has been compared with ZnPc-3, which possesses a carboxylic acid unit as the anchoring group. ZnPc-1/TiO2 shows the best photoactivity with the highest H2 evolution rate of 0.4006 mmol g-1 h-1, which is much higher than that of ZnPc-2/TiO2 and ZnPc-3/TiO2 (0.3319 mmol g-1 h-1 and 0.3555 mmol g-1 h-1, respectively). After 20 h of irradiation, ZnPc-1 produces an H2 production rate of 3.4187 mmol g-1 with a turnover number (TON) of 14863 and a solar-to-hydrogen energy (STH) conversion efficiency of 1.03%, without using a co-catalyst.

Intracellular uptake and fluorescence imaging potential in tumor cell of zinc phthalocyanine.

A near IR absorbing phthalocyanine bearing four binaphtyl group has been synthesized in order to investigate its cytotoxicity and intracellular uptake of sensitizer on MCF-7 (human breast cancer), MDAH (ovarian cancer), HeLa (human epitheloid cervix carcinoma), EMT-6 (mouse breast cancer) and WI-38 (human fibroblast lung) cell lines. ZnPc showed four time higher intracellular uptake in carcinoma cells (MCF-7) than normal (WI-38) cell lines. With the aim of studying in detail the biodistribution feature and tumor nuclear imaging capacity, ZnPc was also labeled with I-131. The efficiency of radiolabeled compound was 95±4.6%. In addition, ZnPc reveals to be very efficient singlet oxygen generators (ΦΔ=0.612 in DMSO) and promising PS for PDT application. In vitro fluorescence imaging study with MCF-7 cells showed that ZnPc localized in cytoplasm of the cells. This results showed that synthesized ZnPc is promising candidate for dual fluorescence/nuclear imaging breast cancer and shows potential PS for PDT application.